The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
The global Neurotrophins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Neurotrophins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Neurotrophins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Neurotrophins include Johnson＆Johnson, Lonza Groups, FibroGen, Scil Proteins GmbH, Merck Serono, Scil Proteins GmbH, PeproTech and GE Healthcare, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Neurotrophins, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neurotrophins.
Report Scope
The Neurotrophins market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Neurotrophins market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Neurotrophins manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company(Partial List)
- Johnson＆Johnson
- Lonza Groups
- FibroGen
- Scil Proteins GmbH
- Merck Serono
- Scil Proteins GmbH
- PeproTech
- GE Healthcare
By Type
- Nerve Growth Factor
- Brain-Derived Neurotrophic Factor
- Dehydroepiandrosterone Sulfate
- Other
By Application
- Alzheimer'S Disease
- Amyotrophic Lateral Sclerosis
- Parkinson'S Disease
- Other
Consumption by Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Netherlands)
- Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
- Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Neurotrophins manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Neurotrophins in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Neurotrophins Market Overview
1.1 Product Overview and Scope of Neurotrophins
1.2 Neurotrophins Segment by Type
1.2.1 Global Neurotrophins Market Value Comparison by Type (2024-2030)
1.2.2 Nerve Growth Factor
1.2.3 Brain-Derived Neurotrophic Factor
1.2.4 Dehydroepiandrosterone Sulfate
1.2.5 Other
1.3 Neurotrophins Segment by Application
1.3.1 Global Neurotrophins Market Value by Application: (2024-2030)
1.3.2 Alzheimer'S Disease
1.3.3 Amyotrophic Lateral Sclerosis
1.3.4 Parkinson'S Disease
1.3.5 Other
1.4 Global Neurotrophins Market Size Estimates and Forecasts
1.4.1 Global Neurotrophins Revenue 2019-2030
1.4.2 Global Neurotrophins Sales 2019-2030
1.4.3 Global Neurotrophins Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Neurotrophins Market Competition by Manufacturers
2.1 Global Neurotrophins Sales Market Share by Manufacturers (2019-2024)
2.2 Global Neurotrophins Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Neurotrophins Average Price by Manufacturers (2019-2024)
2.4 Global Neurotrophins Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Neurotrophins, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Neurotrophins, Product Type & Application
2.7 Neurotrophins Market Competitive Situation and Trends
2.7.1 Neurotrophins Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Neurotrophins Players Market Share by Revenue
2.7.3 Global Neurotrophins Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Neurotrophins Retrospective Market Scenario by Region
3.1 Global Neurotrophins Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Neurotrophins Global Neurotrophins Sales by Region: 2019-2030
3.2.1 Global Neurotrophins Sales by Region: 2019-2024
3.2.2 Global Neurotrophins Sales by Region: 2025-2030
3.3 Global Neurotrophins Global Neurotrophins Revenue by Region: 2019-2030
3.3.1 Global Neurotrophins Revenue by Region: 2019-2024
3.3.2 Global Neurotrophins Revenue by Region: 2025-2030
3.4 North America Neurotrophins Market Facts & Figures by Country
3.4.1 North America Neurotrophins Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Neurotrophins Sales by Country (2019-2030)
3.4.3 North America Neurotrophins Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Neurotrophins Market Facts & Figures by Country
3.5.1 Europe Neurotrophins Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Neurotrophins Sales by Country (2019-2030)
3.5.3 Europe Neurotrophins Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Neurotrophins Market Facts & Figures by Country
3.6.1 Asia Pacific Neurotrophins Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Neurotrophins Sales by Country (2019-2030)
3.6.3 Asia Pacific Neurotrophins Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Neurotrophins Market Facts & Figures by Country
3.7.1 Latin America Neurotrophins Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Neurotrophins Sales by Country (2019-2030)
3.7.3 Latin America Neurotrophins Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Neurotrophins Market Facts & Figures by Country
3.8.1 Middle East and Africa Neurotrophins Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Neurotrophins Sales by Country (2019-2030)
3.8.3 Middle East and Africa Neurotrophins Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Neurotrophins Sales by Type (2019-2030)
4.1.1 Global Neurotrophins Sales by Type (2019-2024)
4.1.2 Global Neurotrophins Sales by Type (2025-2030)
4.1.3 Global Neurotrophins Sales Market Share by Type (2019-2030)
4.2 Global Neurotrophins Revenue by Type (2019-2030)
4.2.1 Global Neurotrophins Revenue by Type (2019-2024)
4.2.2 Global Neurotrophins Revenue by Type (2025-2030)
4.2.3 Global Neurotrophins Revenue Market Share by Type (2019-2030)
4.3 Global Neurotrophins Price by Type (2019-2030)
5 Segment by Application
5.1 Global Neurotrophins Sales by Application (2019-2030)
5.1.1 Global Neurotrophins Sales by Application (2019-2024)
5.1.2 Global Neurotrophins Sales by Application (2025-2030)
5.1.3 Global Neurotrophins Sales Market Share by Application (2019-2030)
5.2 Global Neurotrophins Revenue by Application (2019-2030)
5.2.1 Global Neurotrophins Revenue by Application (2019-2024)
5.2.2 Global Neurotrophins Revenue by Application (2025-2030)
5.2.3 Global Neurotrophins Revenue Market Share by Application (2019-2030)
5.3 Global Neurotrophins Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Johnson＆Johnson
6.1.1 Johnson＆Johnson Corporation Information
6.1.2 Johnson＆Johnson Description and Business Overview
6.1.3 Johnson＆Johnson Neurotrophins Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Johnson＆Johnson Neurotrophins Product Portfolio
6.1.5 Johnson＆Johnson Recent Developments/Updates
6.2 Lonza Groups
6.2.1 Lonza Groups Corporation Information
6.2.2 Lonza Groups Description and Business Overview
6.2.3 Lonza Groups Neurotrophins Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Lonza Groups Neurotrophins Product Portfolio
6.2.5 Lonza Groups Recent Developments/Updates
6.3 FibroGen
6.3.1 FibroGen Corporation Information
6.3.2 FibroGen Description and Business Overview
6.3.3 FibroGen Neurotrophins Sales, Revenue and Gross Margin (2019-2024)
6.3.4 FibroGen Neurotrophins Product Portfolio
6.3.5 FibroGen Recent Developments/Updates
6.4 Scil Proteins GmbH
6.4.1 Scil Proteins GmbH Corporation Information
6.4.2 Scil Proteins GmbH Description and Business Overview
6.4.3 Scil Proteins GmbH Neurotrophins Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Scil Proteins GmbH Neurotrophins Product Portfolio
6.4.5 Scil Proteins GmbH Recent Developments/Updates
6.5 Merck Serono
6.5.1 Merck Serono Corporation Information
6.5.2 Merck Serono Description and Business Overview
6.5.3 Merck Serono Neurotrophins Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Merck Serono Neurotrophins Product Portfolio
6.5.5 Merck Serono Recent Developments/Updates
6.6 Scil Proteins GmbH
6.6.1 Scil Proteins GmbH Corporation Information
6.6.2 Scil Proteins GmbH Description and Business Overview
6.6.3 Scil Proteins GmbH Neurotrophins Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Scil Proteins GmbH Neurotrophins Product Portfolio
6.6.5 Scil Proteins GmbH Recent Developments/Updates
6.7 PeproTech
6.6.1 PeproTech Corporation Information
6.6.2 PeproTech Description and Business Overview
6.6.3 PeproTech Neurotrophins Sales, Revenue and Gross Margin (2019-2024)
6.4.4 PeproTech Neurotrophins Product Portfolio
6.7.5 PeproTech Recent Developments/Updates
6.8 GE Healthcare
6.8.1 GE Healthcare Corporation Information
6.8.2 GE Healthcare Description and Business Overview
6.8.3 GE Healthcare Neurotrophins Sales, Revenue and Gross Margin (2019-2024)
6.8.4 GE Healthcare Neurotrophins Product Portfolio
6.8.5 GE Healthcare Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Neurotrophins Industry Chain Analysis
7.2 Neurotrophins Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Neurotrophins Production Mode & Process
7.4 Neurotrophins Sales and Marketing
7.4.1 Neurotrophins Sales Channels
7.4.2 Neurotrophins Distributors
7.5 Neurotrophins Customers
8 Neurotrophins Market Dynamics
8.1 Neurotrophins Industry Trends
8.2 Neurotrophins Market Drivers
8.3 Neurotrophins Market Challenges
8.4 Neurotrophins Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
